Alkem Laboratories Q1 FY27 Results Analysis: PAT Plunges 21.7%, Margin Compresses 140 bps
Alkem Laboratories Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 3,740.20 Cr (+10.90% YoY) and PAT growth of -21.70% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 14, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 3,740.20 Cr (+10.90% YoY) |
| PAT (Q1) | Rs. 520.00 Cr (-21.70% YoY) |
| EBITDA margin | 20.50% (-140 bps YoY) |
| EPS (Q1) | Rs. 43.49 (-21.70% YoY) |
| Market cap | Rs. 64,546.71 Cr |
| CMP | Rs. 5,368.00 |
Quarter Snapshot
Revenue grew 10.9% YoY but EBITDA margin compressed 140 bps and PAT declined 21.7% due to tax rate normalization and cost pressures. Management missed guidance on US revenue, margin improvement, and tax rate, while domestic outperformance and non-US international growth were bright spots. Post-quarter events include Daman OAI classification and Occlutech acquisition, adding uncertainty.
Key Investment Insights
Key Positives
- Domestic revenue grew 10.3% YoY outperforming IPM by 100 bps.
- Non-US international revenue grew 34.5% YoY, contributing 12.9% of sales.
- EBITDA margin of 20.5% was within the guided 20-21% band.
- Net cash improved to Rs.5,764 Cr from Rs.5,474 Cr QoQ.
- Gross margin expanded 2.6 ppt YoY to 67.9%.
Risk Factors
- US revenue growth of 6.5% INR implies USD decline, missing high single-digit USD guidance.
- EBITDA margin compressed 140 bps YoY due to employee cost growth of 16.7% and other expenses growth of 25.6%.
- Effective tax rate surged to 32.4% from 13.3% YoY, causing PAT decline of 21.7%.
- Daman facility received OAI classification post-quarter, overhang on US business.
- CEO resignation effective 30-Jun-2026 with no successor announced.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.